NPI: 1871863860 · HOPE, AR 71801 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/06/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 01/06/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 15,081 | $125K |
| 2019 | 14,080 | $101K |
| 2020 | 12,961 | $98K |
| 2021 | 11,972 | $80K |
| 2022 | 8,158 | $85K |
| 2023 | 4,612 | $76K |
| 2024 | 1,875 | $27K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 22,395 | 1,643 | $254K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 25,572 | 1,249 | $111K |
| J1270 | Injection, doxercalciferol, 1 mcg | 12,875 | 997 | $53K |
| 83970 | 626 | 494 | $52K | |
| 82728 | 379 | 355 | $39K | |
| 82108 | 166 | 147 | $31K | |
| 83550 | 364 | 342 | $16K | |
| 83540 | 363 | 341 | $14K | |
| A4657 | Syringe, with or without needle, each | 1,079 | 979 | $6K |
| 85041 | 813 | 731 | $5K | |
| 85048 | 801 | 721 | $4K | |
| 82947 | 58 | 52 | $3K | |
| 82746 | 13 | 12 | $2K | |
| J1756 | Injection, iron sucrose, 1 mg | 2,952 | 686 | $1K |
| G0008 | Administration of influenza virus vaccine | 69 | 52 | $401.78 |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 26 | 13 | $399.75 |
| 90674 | 45 | 40 | $177.15 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 129 | 51 | $0.00 |
| 0124A | 14 | 12 | $0.00 |